NUSAP1 and cancer: Notably, four compounds, namely MS-275 (Entinostat), 4,5-dianilinophthalimide (DAPH), W-13, and arachidonyl-trifluoromethane (AACOCF3), exhibited significantly lower scores in most cancer types, indicating their potential to inhibit pro-oncogenic effects mediated by NUSAP1 (Figure 8 and Supplementary Table S6).